Polyarginine-Mediated Protein Delivery to Dendritic Cells Presents Antigen More Efficiently onto MHC Class I and Class II and Elicits Superior Antitumor Immunity-Reference-Cited by-同舟云学术

Polyarginine-Mediated Protein Delivery to Dendritic Cells Presents Antigen More Efficiently onto MHC Class I and Class II and Elicits Superior Antitumor Immunity

Published:2006-08 Issue:8 Volume:126 Page:1804-1812
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Mitsui Hiroshi,Inozume Takashi,Kitamura Reiko,Shibagaki Naotaka,Shimada Shinji

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference50 articles.

1. Clinical significance of defective dendritic cell differentiation in cancer;Almand;Clin Cancer Res,2000

2. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells;Antony;J Immunol,2005

3. Dendritic cells: immunobiology and cancer immunotherapy;Ardavin;Immunity,2004

4. The role of IFN-γ in tumor transplantation immunity and inhibition of chemical carcinogenesis;Blankenstein;Curr Opin Immunol,2003

5. Monitoring secretory membrane with FM1-43 fluorescence;Cochilla;Annu Rev Neurosci,1999

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions;Cell & Bioscience;2024-02-17

2. Self-adjuvanted l-arginine-modified dextran-based nanogels for sustained local antigenic protein delivery to antigen-presenting cells and enhanced cellular and humoral immune responses;Biomaterials Science;2024

3. Antigen cross-presentation in dendric cells: From bench to bedside;Biomedicine & Pharmacotherapy;2023-12

4. Mucosal SARS-CoV-2 Nanoparticle Vaccine Based on Mucosal Adjuvants and Its Immune Effectiveness by Intranasal Administration;ACS Applied Materials & Interfaces;2023-07-19

5. Toxicity and Immune Response;CPP, Cell-Penetrating Peptides;2023